Pretreatment neutrophil-to-lymphocyte/monocyte-to-lymphocyte ratio as prognostic biomarkers in glioma patients

• S.T. Chim,
• P. Sanfilippo,
• T.J. O'Brien,
• K.A. Drummond,
• M. Monif

Affiliations

S.T. Chim

Monash University, Faculty of Medicine, Nursing and Health Sciences, Clayton, Australia; Royal Melbourne Hospital, Melbourne Brain Centre, Parkville, Australia; Royal Melbourne Hospital, Department of Neurology, Parkville, Australia

P. Sanfilippo

Monash University, Department of Neuroscience, Melbourne, Australia

T.J. O'Brien

Monash University, Faculty of Medicine, Nursing and Health Sciences, Clayton, Australia; Royal Melbourne Hospital, Melbourne Brain Centre, Parkville, Australia; Alfred Health, Department of Neurology, Prahran, Australia; Monash University, Department of Neuroscience, Melbourne, Australia

K.A. Drummond

The University of Melbourne, Department of Neurosurgery, Parkville, Australia; Royal Melbourne Hospital, Department of Neurosurgery, Parkville, Australia

M. Monif

Monash University, Faculty of Medicine, Nursing and Health Sciences, Clayton, Australia; Royal Melbourne Hospital, Melbourne Brain Centre, Parkville, Australia; Royal Melbourne Hospital, Department of Neurology, Parkville, Australia; Alfred Health, Department of Neurology, Prahran, Australia; Monash University, Department of Neuroscience, Melbourne, Australia